Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels and liver fibrosis: A meta-analysis

Clinical significance of serumWisteria floribundaagglutinin positive Mac-2-binding protein level in non-alcoholic steatohepatitis

(2016) Hiroki Nishikawa et al.   HEPATOLOGY RESEARCH

Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia

(2016) Naoya Yamada et al.   JOURNAL OF GASTROENTEROLOGY

Development of hepatocellular carcinoma in patients with hepatitis C virus infection who achieved sustained virological response following interferon therapy: A large-scale, long-term cohort study

(2016) Yuko Nagaoki et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C: a comparative study

(2016) H. Nishikawa et al.   JOURNAL OF VIRAL HEPATITIS

The ability of Hepascore to predict liver fibrosis in chronic liver disease: a meta-analysis

(2016) Yi Huang et al.   LIVER INTERNATIONAL

Serum WFA+-M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection

(2016) Xia Zou et al.   LIVER INTERNATIONAL

Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus

(2016) Ja Yoon Heo et al.   MEDICINE

Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis

(2015) Takeji Umemura et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Hepatitis C Virus Treatment: Is It Possible To Cure All Hepatitis C Virus Patients?

(2015) Andrew J. Muir et al.   Clinical Gastroenterology and Hepatology

Wisteria floribundaagglutinin positive human Mac-2-binding protein as a predictor of hepatocellular carcinoma development in chronic hepatitis C patients

(2015) Nobuharu Tamaki et al.   HEPATOLOGY RESEARCH

Impact of serumWisteria floribundaagglutinin positive Mac-2-binding protein and serum interferon-γ-inducible protein-10 in primary biliary cirrhosis

(2015) Hiroki Nishikawa et al.   HEPATOLOGY RESEARCH

Impact of serum glycosylatedWisteria floribundaagglutinin positive Mac-2 binding protein levels on liver functional reserves and mortality in patients with liver cirrhosis

(2015) Tatsunori Hanai et al.   HEPATOLOGY RESEARCH

Clinical significance of serumWisteria floribundaagglutinin positive Mac-2-binding protein level and high-sensitivity C-reactive protein concentration in autoimmune hepatitis

(2015) Hiroki Nishikawa et al.   HEPATOLOGY RESEARCH

Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma

(2015) Masato Fujiyoshi et al.   JOURNAL OF GASTROENTEROLOGY

Serum WFA+-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection

(2015) Hidenori Toyoda et al.   LIVER INTERNATIONAL

Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response

(2015) Ryu Sasaki et al.   PLoS One

Elevated serum levels ofWisteria floribundaagglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients

(2014) Kazumi Yamasaki et al.   HEPATOLOGY

A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis

(2014) Takeo Toshima et al.   JOURNAL OF GASTROENTEROLOGY

Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease

(2014) Masanori Abe et al.   JOURNAL OF GASTROENTEROLOGY

QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies

(2013) Penny F. Whiting   ANNALS OF INTERNAL MEDICINE

α-fetoprotein levels after interferon therapy and risk of hepatocarcinogenesis in chronic hepatitis C

(2013) Yasuhiro Asahina et al.   HEPATOLOGY

A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis

(2013) Atsushi Kuno et al.   Scientific Reports

LecT-hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients

(2012) Kiyoaki Ito et al.   HEPATOLOGY

Assessment of Fibrosis and Cirrhosis in Liver Biopsies: An Update

(2011) Giacomo Germani et al.   SEMINARS IN LIVER DISEASE

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY